Inside EU Health Inside EU Health: Ireland’s health priorities; pharmacies and preparedness Ireland’s Presidency of the EU will link health and competitiveness; PGEU outlines the vital role of community pharmacies in preparedness
Irish Presidency Ireland’s Presidency of the EU will link health and competitiveness Regulatory reform will headline Ireland's EU Presidency agenda, with the Biotech Act and medical devices overhaul leading negotiations
Inside EU Health Inside EU Health: Biotech Act; EU budget; patient organisations ENVI committee raises doubts over Biotech Act SPC extension; 490 health experts urge EU to ring-rence €10 billion for health in EU budget; barometer on the involvement of patient organisations
Biotech Act ENVI opinion signals early resistance to Biotech Act SPC extension The European Parliament's Environment, Climate and Food Safety Committee (ENVI) has delivered the first parliamentary opinion on the European Commission's proposed Biotech Act
Biotech Act Commission estimates the cost of Biotech Act protections at €210 million per year A Commission Staff Working Document supporting the Biotech Act I presented in December shows that the estimated cost of an extension to supplementary protection certificates could exceed €210 million per year
Inside EU Health Inside EU Health: Ebola update; nicotine pouches; biosecurity; WHA; hantavirus Ebola declared emergency of international concern; WHO warns nicotine pouches risk hooking a new generation; EuropaBio ups efforts on biosecurity; World Health Assembly kicks off; EU activates crisis response mechanism to monitor hantavirus outbreak
Cypriot presidency EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi Várhelyi estimated reforms could lower business costs by 20-25 percent - potentially offsetting the impact of US tariffs and "MFN" pricing.
Inside EU Health Inside EU Health: Europe invests in 10-year preparedness research plan; Biotech Act I rapporteurs; EU and Canada health agencies joint plan; HTA report Europe invests €240 million ten-year pandemic preparedness research; Biotech Act I rapporteurs confirmed; EU and Canada health agencies deepen ties; HTA annual report on first year of implementation
Inside EU Health Inside EU Health: WHO defends itself from US slurs; pilot targets 70-day clinical trial approvals; less than 1% of research spent on key women’s health issues WHO defends itself against US accusations; FAST-EU pilot targets 70-day clinical trial approvals; less than 1% of research funding goes to key women’s health conditions
Inside EU Health Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives 🎄Happy Christmas! The Health Package has arrived: Biotech Act, Targeted fix of medical device and; ‘Safe Hearts Plan’
Biotech Act Europe pushes to regain ground on competitors with new Biotech Act With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise
Inside EU Health Inside EU Health: Biotech Act(s); WHO preparedness; and study on drug spending dynamics Biotech Act(s); WHO preparedness; EMA consults on primates in research; and IQVIA study on drug spending dynamics
Biotech Act Commission takes a two step approach to Biotech Act Commission presses ahead with health-focused Biotech Act I' in 2025, with a broader framework to follow in 2026
Competitiveness Várhelyi sets out his sweeping plans to reshape Europe’s competitiveness in health EU Health Commissioner Várhelyi has many ambitious plans and a tight schedule
